Can we use B-type natriuretic peptides to monitor patients with heart failure?-Reference-Cited by-同舟云学术

Can we use B-type natriuretic peptides to monitor patients with heart failure?

Published:2007-10 Issue:3 Volume:1 Page:349-353
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

McDonagh Theresa A¹,Gardner Roy S²,Chong Kwok S³,Dargie Henry J²⁴

Affiliation:

1. Royal Brompton Hospital, London, UK.

2. Glasgow Royal Infirmary, Scottish National Advanced Heart Failure Service, Glasgow, UK.

3. Southern General Hospital, Glasgow, UK.

4. .

Abstract

The B-type natriuretic peptides (BNPs) now have a well-established role in the diagnosis of heart failure. There is also a wealth of evidence on their ability as prognostic markers in patients with heart failure. The other potential role of BNPs is in the arena of therapy monitoring, although much less is known regarding this putative application. This review summarizes what evidence there is both for and against using BNPs to monitor heart failure patients.

Publisher

Future Medicine Ltd

Subject

Biochemistry, medical,Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/17520363.1.3.349

Reference34 articles.

1. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

2. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations

3. Plasma brain natriuretic peptide in assessment of acute dyspnoea

4. Biochemical detection of left-ventricular systolic dysfunction

5. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea